We are live on ! Find out more
NH

NantHealth, Inc

Delisted

NH was delisted on the 23rd of May, 2023.

45 hedge funds and large institutions have $14.5M invested in NantHealth, Inc in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $330K | Put options by funds: $204K

0% more funds holding

Funds holding: 4545 (0)

0% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 9

23% less capital invested

Capital invested by funds: $18.8M → $14.5M (-$4.34M)

47% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 19

Holders
45
Holders Change
Holders Change %
0%
% of All Funds
0.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
10
Reduced
19
Closed
9
Calls
$330K
Puts
$204K
Net Calls
+$126K
Net Calls Change
+$423K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.99M -$4.37K -110 -0.1%
BlackRock
2
BlackRock
New York
$3.08M -$294K -7,387 -8%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$1.48M +$53.3K +1,341 +3%
State Street
4
State Street
Massachusetts
$1.09M +$85.2K +2,143 +7%
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$968K +$1.04M +26,166 +1,577%
Northern Trust
6
Northern Trust
Illinois
$713K -$109K -2,731 -12%
JP Morgan Chase
7
JP Morgan Chase
New York
$599K -$3.58K -90 -0.5%
GCP
8
GSA Capital Partners
United Kingdom
$380K +$244K +6,145 +129%
N
9
Nuveen
North Carolina
$313K -$9.78K -246 -3%
Morgan Stanley
10
Morgan Stanley
New York
$240K +$250K +6,280 +1,024%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$227K +$17.1K +429 +7%
Charles Schwab
12
Charles Schwab
California
$171K
Citadel Advisors
13
Citadel Advisors
Florida
$151K +$46.6K +1,173 +37%
Renaissance Technologies
14
Renaissance Technologies
New York
$134K +$153K +3,862 New
AllianceBernstein
15
AllianceBernstein
Tennessee
$90K +$3.46K +87 +3%
Simplex Trading
16
Simplex Trading
Illinois
$86K -$9.62K -242 -9%
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$83K -$12.6K -317 -12%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$76K +$87K +2,189 New
AQR Capital Management
19
AQR Capital Management
Connecticut
$69K -$75.9K -1,909 -49%
Group One Trading
20
Group One Trading
Illinois
$69K -$517 -13 -0.7%
Jane Street
21
Jane Street
New York
$69K +$78.8K +1,983 New
EGM
22
Engineers Gate Manager
New York
$63K -$32.9K -828 -31%
Goldman Sachs
23
Goldman Sachs
New York
$61K +$70.3K +1,768 New
VF
24
Virtu Financial
New York
$59K +$66.9K +1,684 New
RhumbLine Advisers
25
RhumbLine Advisers
Massachusetts
$48K -$358 -9 -0.7%

NH Hedge Fund Activity: Q2 2021 in Review

45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q2 2021, worth a combined $14.5M — down 23% from $18.8M a quarter earlier.

Fund positioning in NH was balanced in Q2 2021: 9 funds opened new positions, 9 closed out, 10 added to existing stakes and 19 trimmed.

The largest buyer was Jacobs Levy Equity Management, adding an estimated $1.04M. The largest seller was BlackRock, cutting an estimated $294K.

  • 45 institutional investors held NantHealth, Inc (NH) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $14.5M of NantHealth, Inc stock for Q2 2021, down 23% quarter-over-quarter.
  • 9 funds opened new NantHealth, Inc positions in Q2 2021 and 9 closed out, a net change of 0 holders.
  • The largest NantHealth, Inc buyer in Q2 2021 was Jacobs Levy Equity Management, an estimated $1.04M added.
  • The largest NantHealth, Inc seller in Q2 2021 was BlackRock, an estimated $294K sold.

Based on aggregated 13F filings for Q2 2021.